Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
  • Overview
  • Insights
  • Recognition

About Kayleigh

Kayleigh McGlynn is a litigation associate in the Boston office of Fish & Richardson P.C. Kayleigh was previously a summer associate at Fish.

During law school, Kayleigh served as the electronic supplement editor for the Boston College Law Review and editor-in-chief of the Boston College Intellectual Property & Technology Forum. Kayleigh was a research assistant for J. Donald Monan, S.J., University Professor of Law, Daniel R. Coquillette, working on the Harvard Law School history project. Kayleigh interned with the Boston College Innocence Clinic, where she investigated clients’ cases of wrongful conviction and also advocated for improvements to the Massachusetts statute that provides reentry services and compensation to exonerees. In connection with this clinical work, she was named a Boston College Law School public interest designation fellow and awarded pro bono excellence. Kayleigh also interned with the U.S. Attorney’s office for the District of Massachusetts in the economic crimes unit and cybercrime unit.

Prior to attending law school, Kayleigh worked as a research scientist at a biotechnology company focused in the area of molecular diagnostics. Kayleigh’s work concentrated on the development of reagents for the collection and stabilization of clinical patient samples prior to molecular testing, primarily with polymerase chain reaction (PCR).

Selected Publications

Ms. McGlynn is a contributing author to Fish’s IP Law Essentials.

Preserving Trade Secrets at District Court Hearings and Trials,” co-author with Esha Bandyopadhyay, Fish Litigation Blog (March 11, 2021).

Regulatory And Legislative Actions Set The Tone For Biosimilars In 2021,” co-author with Philip Chen and Jenny Shmuel, Biosimilar Development (March 8, 2021).

Biosimilars 2020 Year in Review,” co-author with Philip Chen and Jenny Shmuel, Fish Litigation Blog (February 4, 2021).

“First Circuit Finds Device Patent Improperly Listed in the Orange Book,” co-author, IP Litigator (September 2020).

How Biosimilars Are Approved and Litigated: Patent Dance Timeline,” co-authored with Grant Rice, Jenny Shmuel, Cheryl Wang, Nicole Williams, Fish IP Law Essentials Blog (August 12, 2020).

First Circuit Finds Device Patent Improperly Listed in the Orange Book,” co-authored with Brian Coggio, Fish Litigation Blog (June 26, 2020).

Introduction to Biologics and Biosimilars,” co-authored with Michael Anderson, Tracea Rice, Jenny Shmuel, Cheryl Wang, Fish IP Law Essentials Blog (June 4, 2020).

How Pandemic-Related Delays Affect Hatch-Waxman Litigants,” co-authored with Geoff Biegler and Madelyn McCormick, Law360 (May 21, 2020).

Patent Local Rules: Knowing Them Well Can Make Litigating Your Case Smoother,” co-authored with Michael Amon, Ricardo Bonilla, Megan Chacon, Madelyn McCormick, Jason Wolff, Fish IP Law Essentials Blog (April 22, 2020).

A Biosimilar’s Guide to the BPCIA Patent Dance: Five Key Questions for Every Biosimilar Applicant to Consider,” co-authored with Michael Anderson, Grant Rice, Jenny Shmuel, and Cheryl Wang, Fish Litigation Blog (April 20, 2020).

“Massachusetts Patent Litigation Wrap Up- August 2019,” written with Matthew Berntsen, Fish Litigation Blog (March 12, 2020).

The Doctrine of Equivalents in BPCIA Litigation,” written with Tasha Francis, Jenny Shmuel, and Tracea Rice, Fish Litigation Blog (December 16, 2019).

Remedying Wrongful Convictions Through DNA Testing: Expanding Post-Conviction Litigants’ Access to DNA Database Searches to Prove Innocence, 60 B.C. L. Rev. 709 (2019)

Incapacitating Dangerous Repeat Offenders (Or Not): Evidentiary Restrictions on Armed Career Criminal Act Sentencing in United States v. King, 59 B.C. L. Rev. E. Supp. 348 (2018)

Focus Areas
Education

J.D. magna cum laude, Order of the Coif, Boston College Law School (2019) Electronic Supplement Editor, Boston College Law Review; Editor-in-Chief, Boston College Intellectual Property & Technology Forum


B.S. summa cum laude, Phi Beta Kappa, Biology, Boston College (2014) Scholar of the College

Admissions
  • Massachusetts 2019

What's trending with Kayleigh

Filter by
Blog
March 11, 2021
Preserving Trade Secrets at District Court Hearings and Trials
Authors: Kayleigh E. McGlynn, Esha Bandyopadhyay
News
March 8, 2021
Fish Attorneys Author Biosimilar Development Article, "Regulatory And Legislative Actions Set The Tone For Biosimilars In 2021"
Articles
News
Blog
February 4, 2021
Biosimilars 2020 Year in Review
Authors: Kayleigh E. McGlynn, Philip K. Chen, Jenny Shmuel, Ph.D.
News
October 29, 2020
Massachusetts Supreme Judicial Court Names 20 Fish Attorneys to Pro Bono Honor Roll
Recognition
News
Blog
August 12, 2020
How Biosimilars Are Approved and Litigated: Patent Dance Timeline
Authors: Kayleigh E. McGlynn, Cheryl Wang, Nicole Williams, Jenny Shmuel, Ph.D.
IP Law Essentials
Blog
June 26, 2020
First Circuit Finds Device Patent Improperly Listed in the Orange Book
Authors: Kayleigh E. McGlynn, Brian D. Coggio
IP Litigation
Life Sciences
News
June 11, 2020
Fish & Richardson Pro Bono Attorneys Assist in Successful Appeal of Permit For Enbridge Unit Pipeline Facility
Media Mention
News
Blog
June 4, 2020
Introduction to Biologics and Biosimilars
Authors: Kayleigh E. McGlynn, Tracea L. Rice, Cheryl Wang, Jenny Shmuel, Ph.D.
Blogs
IP Law Essentials
Blog
April 22, 2020
Patent Local Rules: Knowing Them Well Can Make Litigating Your Case Smoother
Authors: Kayleigh E. McGlynn, Madelyn McCormick, Megan A. Chacon, Jason W. Wolff, Michael A. Amon, Ricardo Bonilla
Blogs
IP Law Essentials
Blog
April 20, 2020
A Biosimilar’s Guide to the BPCIA Patent Dance: Five Key Questions for Every Biosimilar Applicant to Consider
Authors: Kayleigh E. McGlynn, Cheryl Wang, Jenny Shmuel, Ph.D.
IP Litigation
Life Sciences
Blog
March 12, 2020
Massachusetts Patent Litigation Wrap Up – August 2019
Author: Kayleigh E. McGlynn
IP Litigation
Blog
December 16, 2019
The Doctrine of Equivalents in BPCIA Litigation
Authors: Kayleigh E. McGlynn, Tracea L. Rice, Jenny Shmuel, Ph.D.
IP Litigation
Life Sciences
load more topics
TOP